Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward V Loftus

Showing results (21-30 of 471) with videos related to

Pageof 48
Sort By:
Current Gastroenterology Reports|November 6, 2004
Management of extraintestinal manifestations and other complications of inflammatory bowel diseaseEdward V Loftus
The Medical Journal of Australia|March 28, 2021
The increasing burden of inflammatory bowel diseaseEdward V Loftus
Inflammatory Bowel Diseases|February 28, 2003
A matter of life or death: mortality in Crohn's diseaseEdward V Loftus
Gastroenterology Clinics of North America|August 12, 2014
Biologic therapy in inflammatory bowel diseaseEdward V Loftus
Gastroenterology & Hepatology|July 31, 2019
The Impact of Biologic Therapy on Outcomes of Inflammatory Bowel Disease SurgeryEdward V Loftus
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 7, 2007
The burden of inflammatory bowel disease in the United States: a moving target?Edward V Loftus
Gastroenterology|March 27, 2013
Management of severe steroid-refractory ulcerative colitis: cyclosporine or infliximab?Siddharth Singh, Edward V Loftus
Gastroenterology Clinics of North America|October 30, 2020
Nonbiologic Immune Suppression in Ulcerative ColitisValérie Heron, Edward V Loftus
Gastroenterology|December 23, 2014
No risk of malignancy with biologics in inflammatory bowel disease: is the debate over?Maneesh Dave, Edward V Loftus
Journal of Crohn'S & Colitis|June 3, 2017
Bringing the Mucosa to Heal With Vedolizumab in Patients With Inflammatory Bowel DiseaseSatimai Aniwan, Edward V Loftus
Pageof 48

Showing results (21-30 of 471) with videos related to

Sort By:
Pageof 48
Current Gastroenterology Reports|November 6, 2004
Management of extraintestinal manifestations and other complications of inflammatory bowel diseaseEdward V Loftus
The Medical Journal of Australia|March 28, 2021
The increasing burden of inflammatory bowel diseaseEdward V Loftus
Inflammatory Bowel Diseases|February 28, 2003
A matter of life or death: mortality in Crohn's diseaseEdward V Loftus
Gastroenterology Clinics of North America|August 12, 2014
Biologic therapy in inflammatory bowel diseaseEdward V Loftus
Gastroenterology & Hepatology|July 31, 2019
The Impact of Biologic Therapy on Outcomes of Inflammatory Bowel Disease SurgeryEdward V Loftus
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 7, 2007
The burden of inflammatory bowel disease in the United States: a moving target?Edward V Loftus
Gastroenterology|March 27, 2013
Management of severe steroid-refractory ulcerative colitis: cyclosporine or infliximab?Siddharth Singh, Edward V Loftus
Gastroenterology Clinics of North America|October 30, 2020
Nonbiologic Immune Suppression in Ulcerative ColitisValérie Heron, Edward V Loftus
Gastroenterology|December 23, 2014
No risk of malignancy with biologics in inflammatory bowel disease: is the debate over?Maneesh Dave, Edward V Loftus
Journal of Crohn'S & Colitis|June 3, 2017
Bringing the Mucosa to Heal With Vedolizumab in Patients With Inflammatory Bowel DiseaseSatimai Aniwan, Edward V Loftus
Pageof 48